Authors
Loading...
In vitro experiment examines resistance mechanisms to temozolomide in glioblastoma, suggesting cfDNA as a biomarker.
Mankame et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: